# VTCN1

## Overview
VTCN1, also known as B7-H4, is a gene that encodes the protein V-set domain containing T cell activation inhibitor 1, which is a member of the B7 family of immune checkpoint proteins. This protein plays a pivotal role in immune regulation by inhibiting T cell activation and proliferation, thereby contributing to immune homeostasis (Sichani2023Molecular). VTCN1 is particularly significant in maintaining immune tolerance at the maternal-fetal interface during early pregnancy, where it is highly expressed in villous trophoblasts and influences placental development (Zhou2023The). Additionally, VTCN1 is implicated in various pathological conditions, including cancer and autoimmune diseases, where its altered expression can lead to immune evasion by tumors or contribute to disease progression (Cai2021Phenotypic; Albers2013Genetic).

## Function
The VTCN1 gene, also known as B7-H4, encodes a protein that functions as an immune checkpoint molecule, playing a crucial role in immune regulation and maintaining immune homeostasis. In healthy human cells, VTCN1 is involved in suppressing immune responses by inhibiting T cell activation and proliferation, as well as reducing the production of inflammatory cytokines (Sichani2023Molecular). This function is essential for preventing overactive immune responses and maintaining immune tolerance, particularly at the maternal-fetal interface during early pregnancy (Zhou2023The).

VTCN1 is highly expressed in villous trophoblasts during the early weeks of pregnancy, where it influences the balance between syncytialization and invasion, processes critical for placental development (Zhou2023The). The protein's expression is associated with the regulation of major histocompatibility complex (MHC) class I molecules, which affects immune tolerance at the maternal-fetal interface (Zhou2023The). VTCN1 also modulates the phenotype of co-cultured peripheral natural killer (NK) cells, promoting a decidual NK cell-like phenotype typical during pregnancy (Zhou2023The). These roles highlight VTCN1's importance in ensuring a balanced immune environment, crucial for successful pregnancy outcomes.

## Clinical Significance
The VTCN1 gene, also known as B7-H4, plays a significant role in immune regulation and has been implicated in various diseases due to its altered expression and genetic variations. In breast cancer, VTCN1 expression is significantly increased, which may contribute to tumor cells evading immune detection by inhibiting T-cell activation. This overexpression is associated with a higher risk of breast cancer, particularly in individuals with certain single nucleotide polymorphisms (SNPs) such as rs10754339 and rs10801935, which are linked to increased cancer susceptibility (Tsai2014The; Sichani2023Molecular).

In autoimmune conditions like juvenile idiopathic arthritis (JIA), genetic variations in VTCN1, specifically SNPs rs10923223 and rs12046117, are associated with the disease's progression. These SNPs may serve as genetic markers for predicting disease outcomes, highlighting the gene's role in immune system modulation (Albers2013Genetic).

VTCN1 is also involved in placental development, where its expression helps regulate immune tolerance at the maternal-fetal interface. Alterations in VTCN1 expression can affect trophoblast cell differentiation and immune responses, potentially impacting pregnancy outcomes (Zhou2023The).

## Interactions
VTCN1, also known as B7-H4, is involved in various interactions that influence immune responses. It is a member of the B7 family of immune checkpoint proteins and primarily functions by interacting with receptors on T cells, inhibiting their activation and proliferation. This interaction contributes to immune evasion in cancer by reducing T cell-mediated immune responses (Cai2021Phenotypic).

In the context of ovarian cancer, VTCN1 is highly expressed and is associated with the inhibition of T cell proliferation and function. It interacts with a putative receptor on CD4+ T, CD8+ T, NK, and NK T cells, leading to an exhausted T-cell phenotype and reduced cytolytic activity of CD8+ tumor-infiltrating lymphocytes (Cai2021Phenotypic). This interaction is crucial for the immunosuppressive environment observed in tumors.

VTCN1 also plays a role in the differentiation of trophoblast cells derived from human embryonic stem cells. It is involved in guiding differentiation and suppressing pro-inflammatory responses, as well as major histocompatibility complex (MHC) class I expression. This suggests that VTCN1 may promote maternal immune tolerance of trophoblasts and influence their response to pathogens (Zhou2023The).


## References


[1. (Zhou2023The) Jie Zhou, Yuchen Tian, Ying Qu, Madyson Williams, Ye Yuan, Rowan M. Karvas, Megan A. Sheridan, Laura C. Schulz, Toshihiko Ezashi, Michael R. Roberts, and Danny J. Schust. The immune checkpoint molecule, vtcn1/b7-h4, guides differentiation and suppresses proinflammatory responses and mhc class i expression in an embryonic stem cell-derived model of human trophoblast. Frontiers in Endocrinology, March 2023. URL: http://dx.doi.org/10.3389/fendo.2023.1069395, doi:10.3389/fendo.2023.1069395. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2023.1069395)

[2. (Albers2013Genetic) H M Albers, T H C M Reinards, D M C Brinkman, S S M Kamphuis, M A J van Rossum, E PA H Hoppenreijs, H J Girschick, C Wouters, R K Saurenmann, E Bakker, W Verduijn, P Slagboom, T W J Huizinga, R E M Toes, J J Houwing-Duistermaat, R ten Cate, and M W Schilham. Genetic variation invtcn1(b7-h4) is associated with course of disease in juvenile idiopathic arthritis. Annals of the Rheumatic Diseases, 73(6):1198–1201, December 2013. URL: http://dx.doi.org/10.1136/annrheumdis-2013-204466, doi:10.1136/annrheumdis-2013-204466. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/annrheumdis-2013-204466)

[3. (Cai2021Phenotypic) Dongli Cai, Fang Wang, Changgang Wang, and Liping Jin. Phenotypic and functional analyses of b7s1 in ovarian cancer. Frontiers in Molecular Biosciences, July 2021. URL: http://dx.doi.org/10.3389/fmolb.2021.686803, doi:10.3389/fmolb.2021.686803. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2021.686803)

4. (Sichani2023Molecular) Molecular insight into the expression level of an immunosuppression gene, VTCN1, and its regulatory factors in breast cancer patients and non-cancerous samples with a higher level of IgE. This article has 5 citations.

[5. (Tsai2014The) Shih‐Meng Tsai, Szu‐Hsien Wu, Ming‐Feng Hou, Hlio‐Han Yang, and Li‐Yu Tsai. The immune regulator vtcn1 gene polymorphisms and its impact on susceptibility to breast cancer. Journal of Clinical Laboratory Analysis, 29(5):412–418, November 2014. URL: http://dx.doi.org/10.1002/jcla.21788, doi:10.1002/jcla.21788. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcla.21788)